Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study

Authors:

Abstract
No abstract available
Funding Information
  • National Major Scientific and Technological Special Project for Significant New Drugs Development (2014ZX09101002004)
  • Shanghai Science and Technology Innovation Action Project (14431908300, 15XD1520500)
  • Shanghai Pudong District Science and Technology Innovation Action Project (PKJ2014-S06)

This publication has 20 references indexed in Scilit: